all

Register for the NLA Annual Business Meeting by clicking here. 

Join us on Monday, June 8 from 6:00 – 6:30 PM ET for the NLA’s Annual Business Meeting for important NLA updates and award announcements:

/sites/default/files/files/CV_Patient_Mangement_in_the_Era_of_COVID19_Presentation(1).pdf

The NLA has released an official scientific statement on the use of genetic testing in the diagnosis and management of patients with dyslipidemia. The statement provides insights and guidance for health care providers seeking to further their understanding of the benefits, risks and patient preferences of genetic testing.